Debvoise & Plimpton: Federal Cannabis Developments: Executive Order on Marijuana Rescheduling and New Risks for the CBD Industry
23 December 2025 Key Takeaways: On December 18, 2025, President Trump issued an executive order directing his administration to complete the process for reclassifying marijuana under the federal Controlled Substances Act, moving it from Schedule I to Schedule III. The...
Bradley: Trump Orders Marijuana Rescheduled, Broader CBD Access in Major Announcement: What Does It Mean?
By Whitt Steineker & Slates C. Veazey on December 23, 2025 Are you not entertained? In a much-anticipated ceremony in the Oval Office, President Trump signed an executive order that (1) directs the attorney general to expeditiously reschedule marijuana to Schedule...
Goodwin: Bye-Bye 280E: New Executive Order Concerning Cannabis Rescheduling
In a historic development, on December 18, 2025, President Donald Trump signed an Executive Order entitled “Increasing Medical Marijuana And Cannabidiol Research,” directing Attorney General Pam Bondi to “take all necessary steps to complete the rulemaking process...
Feldman: President Trump Issues Executive Order to Move Cannabis to Schedule III of the Controlled Substances Act
Dec 19 On December 18, 2025, President Donald Trump signed an executive order (the “Order”) directing the federal government to move cannabis from Schedule I to Schedule III under the federal Controlled Substances Act (“CSA”). The White House frames the Order as a...
Akerman: Turning Point for Cannabis: What Trump’s Rescheduling Order Means for the Industry
Yesterday, President Donald J. Trump signed an Executive Order directing federal agencies to begin the formal process of rescheduling marijuana under the Controlled Substances Act (CSA) from Schedule I to Schedule III. Although the Executive Order does not immediately...Top 200 Cannabis Lawyers
We Support